Proactive Investors - Run By Investors For Investors

MaxCyte raises £10mln to extend its CARMA platform into a second trial

MaxCyte Inc (LON:MXCT) CEO Doug Doerfler sits down with Proactive at the BIO CEO and Investor Conference in New York.

The company has raised £10mln in a share placing to fund an acceleration of its growth strategy as well as executing “significant commercial opportunities”.

 
Meet Manolete Partners PLC, Arkle Resources PLC, Royal Road Minerals and Neo Lithium Corp at our event, London , 04 April 2019. Register here »
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY TO US PERSONS, AS DEFINED IN REGULATIONS PROMULGATED UNDER THE US SECURITIES ACT 1933, AS AMENDED (THE “US SECURITIES ACT”), OR IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE OR PUBLICATION WOULD BE UNLAWFUL.”
View full MXCT profile View Profile

MaxCyte Timeline

Video
November 13 2018

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use